O

Oberland Capital

21 employees

Oberland Capital provides innovative financing solutions to companies .

Investor insights

Sectors invested in

Health Care6
Biotechnology6
Pharmaceutical5
Therapeutics2
Small Molecule1
Biopharma1
Hospitality1
Manufacturing1
Health Diagnostics1
Emergency Medicine1
Medical1
Acute Care1
Antibiotics1
Antimicrobials1
Statin1
Research & Development1
LDL-C1
Late-state Pharmaceutical Company1
Cardiovascular1

Funding rounds participated in

$83M sweet spot round size

Most of their 9 investments are in rounds between $27M and $90M

Investor type

Private Equity Firm
Venture Capital

Basic info

Industry

financial services

Sectors

Financial Services
Asset Management
Venture Capital

Date founded

2013

Investments made

U

Undisclosed raised undisclosed on January 10, 2023

Investors: Oberland Capital

Z

Zealand Pharma raised $200M on December 14, 2021

Investors: Oberland Capital

C

Centessa Pharmaceuticals raised $300M on October 4, 2021

Investors: Oberland Capital

E

Esperion Therapeutics raised $50M on April 26, 2021

Investors: Oberland Capital

M

Mirum Pharmaceuticals raised $10M on December 9, 2020

Investors: Oberland Capital

P

Primmune Therapeutics raised $27M on October 27, 2020

Investors: Samsara BioCapital, Polaris Partners and Oberland Capital

N

NorthStar Medical Radioisotopes, LLC raised $75M on April 23, 2019

Investors: Oberland Capital

U

Undisclosed raised $90M on October 26, 2017

Investors: Oberland Capital

M

Melinta Therapeutics raised $90M on June 29, 2017

Investors: Oberland Capital

FAQ